QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
28.33
-0.37 (-1.29%)
Jun 27, 2025, 2:28 PM - Market open
QuidelOrtho Revenue
QuidelOrtho had revenue of $692.80M in the quarter ending March 30, 2025, a decrease of -2.56%. This brings the company's revenue in the last twelve months to $2.76B, down -3.42% year-over-year. In the year 2024, QuidelOrtho had annual revenue of $2.78B, down -7.17%.
Revenue (ttm)
$2.76B
Revenue Growth
-3.42%
P/S Ratio
0.70
Revenue / Employee
$418,894
Employees
6,600
Market Cap
1.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | 1.13B | 210.66% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
QDEL News
- 23 days ago - QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics - PRNewsWire
- 5 weeks ago - QuidelOrtho to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade) - Seeking Alpha
- 7 weeks ago - QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - QuidelOrtho Reports First Quarter 2025 Financial Results - Business Wire
- 2 months ago - QuidelOrtho to Report First Quarter 2025 Financial Results - Business Wire
- 3 months ago - QuidelOrtho® Introduces Results Manager™ System - Business Wire
- 4 months ago - QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference - Business Wire